Quantitative Systematic Strategies’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-14,852
Closed -$960K 543
2021
Q1
$960K Sell
14,852
-24,948
-63% -$1.61M 0.15% 238
2020
Q4
$2.32M Buy
+39,800
New +$2.4M 0.33% 77
2019
Q2
Sell
-14,465
Closed -$940K 507
2019
Q1
$940K Sell
14,465
-10,945
-43% -$727K 0.23% 142
2018
Q4
$1.59M Sell
25,410
-903
-3% -$63.1K 0.36% 76
2018
Q3
$2.03M Buy
26,313
+16,319
+163% +$1.23M 0.39% 70
2018
Q2
$708K Buy
+9,994
New +$706K 0.13% 267
2018
Q1
Sell
-6,350
Closed -$455K 673
2017
Q4
$455K Buy
+6,350
New +$482K 0.12% 298
2017
Q3
Sell
-29,979
Closed -$2.12M 490
2017
Q2
$2.12M Buy
29,979
+4,016
+15% +$267K 0.54% 50
2017
Q1
$1.76M Buy
25,963
+10,026
+63% +$705K 0.49% 89
2016
Q4
$1.15M Buy
15,937
+1,040
+7% +$77.3K 0.47% 64
2016
Q3
$1.16M Buy
14,897
+3,973
+36% +$323K 0.43% 79
2016
Q2
$899K Buy
10,924
+2,765
+34% +$245K 0.42% 75
2016
Q1
$750K Buy
+8,159
New +$736K 0.29% 138
2015
Q4
Sell
-4,577
Closed -$449K 905
2015
Q3
$449K Buy
+4,577
New +$508K 0.22% 163
2015
Q2
Sell
-6,974
Closed -$695K 550
2015
Q1
$695K Sell
6,974
-2,800
-29% -$284K 0.19% 162
2014
Q4
$933K Buy
+9,774
New +$1.01M 0.37% 91
2014
Q2
Sell
-4,113
Closed -$282K 282
2014
Q1
$282K Sell
4,113
-13,842
-77% -$1.09M 0.23% 195
2013
Q4
$1.35M Buy
+17,955
New +$1.25M 1.09% 17

Other funds holding GILD

Quantitative Systematic Strategies's GILD Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 14,852 shares — an estimated $960K sold.

Quantitative Systematic Strategies first reported a position in GILD in Q4 2013 and held it in 18 quarters. The position peaked at $2.32M in Q4 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,852 Gilead Sciences shares in Q2 2021, an estimated $960K.
  • Quantitative Systematic Strategies first reported a position in Gilead Sciences in Q4 2013 and held it in 18 quarters.
  • Quantitative Systematic Strategies's Gilead Sciences position peaked at $2.32M in Q4 2020.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.